Imaging biomarkers in NAFLD: Could they avoid liver biopsy?
The diagnosis of NASH is critically important for clinical trials and clinical practice. Today, the gold standard to diagnose NASH is a liver biopsy…
Read MorePHASE 3 DEVELOPMENT
There are many compounds in development for the management of NASH. It is very important to understand the path to regulatory approval
Read MorePPAR’S AS CRITICAL REGULATORS OF METABOLISM
The slide above illustrates the role of PPARα, PPARβ/δ and PPARγ as key regulators of lipid metabolism, inflammation and glucose..
Read More